Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients with Stage IV Colorectal Cancer: A Canadian Province Experience

Clinical Colorectal Cancer

Volumn 14, Issue 4, 2015, Pages e41-e47

  Ahmed, Shahid ^a,b,c   Fields, Anthony ^d   Pahwa, Punam ^c   Chandra Kanthan, Selliah ^b   Zaidi, Adnan ^a,b   Le, Duc ^a,b   Haider, Kamal ^a,b   Reeder, Bruce ^c   Leis, Anne ^c  

^a SASKATCHEWAN CANCER AGENCY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Asymptomatic patients; Primary tumor; Stage IV colorectal cancer; Surgery; Survival

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANADIAN; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; EXPERIENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; PRIMARY TUMOR; CANCER STAGING; COHORT ANALYSIS; COLORECTAL NEOPLASMS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SASKATCHEWAN; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SASKATCHEWAN; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84947866022     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2015.05.008     Document Type: Article

References (16)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics [published erratum in 2011; 61:134] CA Cancer J Clin 61 2011 69 90
2. S. Ahmed, R.K. Shahid, A. Leis, and et al. Should non-curative resection of primary tumor be performed in patients with stage IV colorectal cancer? A systematic review and meta-analysis Curr Oncol 20 2013 e420 e441
3. L.E. McCahill, G. Yothers, S. Sharif, and et al. Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10 J Clin Oncol 30 2012 3223 3228
4. C. Clancy, J.P. Burke, M. Barry, and et al. A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival Ann Surg Oncol 21 2014 3900 3908
5. S. Ahmed, A. Leis, A. Fields, and et al. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study Cancer 120 2014 683 691
6. A.D. Cook, R. Single, and L.E. McCahill Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of Surveillance, Epidemiology, and End Results data 1988-2000 Ann Surg Oncol 12 2005 637 645
7. W.Y. Tsang, A. Ziogas, B.S. Lin, and et al. Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV colorectal cancer: a survival analysis J Gastrointest Surg 18 2014 592 598
8. R.C. Flanigan, S.E. Salmon, B.A. Blumenstein, and et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer N Engl J Med 345 2001 1655 1659
9. G.H. Mickisch, A. Garin, H. van Poppel, and et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial Lancet 358 2001 966 970
10. E. Harris, M. Barry, and M.R. Kell Meta-analysis to determine if surgical resection of the primary tumor in the setting of stage IV breast cancer impacts survival Ann Surg Oncol 20 2013 2828 2834
11. T.E. Goranova, M. Ohue, Y. Shimoharu, and K. Kato Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors Clin Exp Metastasis 28 2011 427 435
12. B. Cambien, P. Richard-Fiardo, B.F. Karimdjee, and et al. CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRb in colorectal carcinoma PLoS One 6 2011 e28842
13. H.J. Chen, R. Edwards, S. Tucci, and et al. Chemokine 25-induced signalling suppresses colon cancer invasion and metastasis J Clin Invest 122 2012 3184 3196
14. S. Ahmed, G. Wei, J. Lim, and et al. Immune response and its correlation with the disease activity in patients with advanced colorectal cancer (aCRC): results from a prospective observational study J Clin Oncol 32 suppl 3 2014 (abstract 471)
15. N.N. Rahbari, F. Lordick, C. Fink, and et al. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS - a randomised controlled multicentre trial (ISRCTN30964555) BMC Cancer 12 2012 142
16. Dutch Colorectal Cancer Group. CAIRO 4. Available at: http://www.dccg.nl/dccg-trials/cairo-4. Accessed: June 14, 2014.